Event ESC-Congress 16th Mar. 2016, Brussels, Belgium This will feature an Interactive workshop on patient engagement in healthcare, The event is run for the European Society of Cardiology ….more
Final year of JA-CHRODIS Project
JA-CHRODIS Project Partners and Stakeholders discuss way forward for final year On 4th February, JA-CHRODIS held its 2nd General Assembly which all Associated and Collaborating Partners of the Joint Action were invited. Partners heard how two mechanisms were needed in order to collect information on one hand, and implement the practices in every day…
Alzheimer’s disease: More difficult to slow than previously thought
Progression of Alzheimer’s is more difficult to slow than previously thought Being physically and mentally stimulated helps delay cognitive decline but the alterations to the brain involved in Alzheimer’s disease do not seem be affected in most individuals. The progression of Alzheimer’s disease appears more difficult to slow than previously thought. In past few years,…
ENVI Committee meeting 23 Feb 2016
ENVI Committee meeting held, Brussels, 23 Feb. 2016. Members voted on two questions Zika virus Mandatory indication of the country of origin or place of provenance for certain foods. Opinions on implementing Energy efficiency Directive will be considered. Ms Andrea Ammon, Acting Director ECDC presented her agency’s annual exchange of views with Members The EU…
Secure health information needed!
S-health is the obvious patient priority It’s not M-health or E-health but very S-ecure health that is needed!! Healthcare and government are a higher target than the retail sector for most targetted for data breaches, according to Gemalto. security firm 1,673 data breaches meant that 707 million data records were compromised worldwide during 2015, according…
Treatment recommendation: advanced skin cancer
Treatment recommendation for advanced skin cancer Advanced (unresectable or metastatic) melanoma. 18 Feb 2016 NICE final guidance recommending nivolumab as monotherapy for treating advanced skin cancer. Nivolumab called Opdivo, and manufactured by Bristol Myers Squibb is to be made available on the NHS as a treatment option for patients with advanced unresectable or metastatic melanoma.…
Ireland: €5.7 m for health research leaders
HRB invests €5.7 million in research leaders in health The Health Research Board. Ireland has appointed four new Research Leaders in the areas of suicide prevention, safe prescribing, dementia care and team leadership in the health services. The awards should build capacity in areas of strategic importance for health delivery in Ireland. and ensure senior…
Pay attention to pain
Its womens no.1 Killer So paying attention to pain could save your life. Heart disease is the number one killer of women, yet the American Heart Association says sonly one in five American women believes heart disease is her greatest health threat. The commonest heart attack symptom in men and women is chest pain or…
Barley may increase hormones so regulating metabolism and appetite
Barley ‘increased gut hormones that regulate metabolism and appetite’ Researchers claim that the positive health effects occur when the dietary fibers in the barley kernel reach the gut, then they increase good bacteria and instigate the release of specific hormones. “After eating the bread made out of barley kernel, we saw an increase in gut…
Facial hair may tackle antibiotic resistance
Nature gives men bacteria fighting beards so improves their antibiotic resistance! Facial hair could be a key to developing new antibiotics, claims a team led by Dr. Adam Roberts, microbiologist at University College London (UCL) in the UK, They have spent recent years attempting to uncover new medicines that overcome drug resistance, a major public…